nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—ADRA2C—Hemostasis—CDK2—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—GNAQ—ocular cancer	0.00138	0.00138	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TFDP1—ocular cancer	0.00136	0.00136	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SAG—ocular cancer	0.00136	0.00136	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—GNAQ—ocular cancer	0.00136	0.00136	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—GNAQ—ocular cancer	0.00136	0.00136	CbGpPWpGaD
Droxidopa—PAH—Disease—EP300—ocular cancer	0.00135	0.00135	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—GNA11—ocular cancer	0.00135	0.00135	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—GNAQ—ocular cancer	0.00135	0.00135	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—GNAQ—ocular cancer	0.00134	0.00134	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—E2F3—ocular cancer	0.00134	0.00134	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—GNA11—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—GNAQ—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Droxidopa—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—E2F3—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—E2F3—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—GNA11—ocular cancer	0.0013	0.0013	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—E2F5—ocular cancer	0.0013	0.0013	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—E2F4—ocular cancer	0.00127	0.00127	CbGpPWpGaD
Droxidopa—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.00126	0.00126	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—GNAQ—ocular cancer	0.00126	0.00126	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RBL1—ocular cancer	0.00125	0.00125	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TFDP1—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—E2F3—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—GNAQ—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TFDP1—ocular cancer	0.00123	0.00123	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—E2F3—ocular cancer	0.00122	0.00122	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—HDAC1—ocular cancer	0.00122	0.00122	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TFDP1—ocular cancer	0.00122	0.00122	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—GNAQ—ocular cancer	0.00121	0.00121	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—GNA11—ocular cancer	0.00121	0.00121	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—E2F5—ocular cancer	0.00121	0.00121	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—E2F4—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—GNA11—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Droxidopa—PAH—Disease—MYC—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Droxidopa—PAH—Disease—TGFB1—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RBL1—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TFDP1—ocular cancer	0.00115	0.00115	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—CDK2—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Droxidopa—PAH—Metabolism—EP300—ocular cancer	0.00113	0.00113	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TFDP1—ocular cancer	0.00113	0.00113	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—GNAQ—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—GNAQ—ocular cancer	0.0011	0.0011	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—GNA11—ocular cancer	0.0011	0.0011	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CDKN2B—ocular cancer	0.00109	0.00109	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MAML2—ocular cancer	0.00108	0.00108	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—E2F3—ocular cancer	0.00108	0.00108	CbGpPWpGaD
Droxidopa—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.00108	0.00108	CbGpPWpGaD
Droxidopa—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.00105	0.00105	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—GNAQ—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TFDP1—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—E2F3—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—E2F1—ocular cancer	0.001	0.001	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MAML2—ocular cancer	0.000988	0.000988	CbGpPWpGaD
Droxidopa—ADRA2B—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000986	0.000986	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MAML2—ocular cancer	0.000979	0.000979	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MAML2—ocular cancer	0.000966	0.000966	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—GNA11—ocular cancer	0.000954	0.000954	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—GNA11—ocular cancer	0.000946	0.000946	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TFDP1—ocular cancer	0.000935	0.000935	CbGpPWpGaD
Droxidopa—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000933	0.000933	CbGpPWpGaD
Droxidopa—PAH—Disease—HRAS—ocular cancer	0.000927	0.000927	CbGpPWpGaD
Droxidopa—ADRA2C—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000921	0.000921	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MAML2—ocular cancer	0.000914	0.000914	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MAML2—ocular cancer	0.0009	0.0009	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—GNAQ—ocular cancer	0.000887	0.000887	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—GNAQ—ocular cancer	0.000879	0.000879	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—GNA11—ocular cancer	0.000862	0.000862	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—GNA11—ocular cancer	0.000854	0.000854	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—GNA11—ocular cancer	0.000843	0.000843	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—EP300—ocular cancer	0.000841	0.000841	CbGpPWpGaD
Droxidopa—PAH—Disease—AKT1—ocular cancer	0.000818	0.000818	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—GNAQ—ocular cancer	0.000801	0.000801	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MAML2—ocular cancer	0.000799	0.000799	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—GNA11—ocular cancer	0.000798	0.000798	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—GNAQ—ocular cancer	0.000794	0.000794	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—HDAC1—ocular cancer	0.000793	0.000793	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—EP300—ocular cancer	0.000786	0.000786	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—GNA11—ocular cancer	0.000785	0.000785	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—GNAQ—ocular cancer	0.000784	0.000784	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GNA11—ocular cancer	0.000775	0.000775	CbGpPWpGaD
Droxidopa—ADRA2A—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000748	0.000748	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MAML2—ocular cancer	0.000742	0.000742	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—GNAQ—ocular cancer	0.000741	0.000741	CbGpPWpGaD
Droxidopa—DDC—Metabolism—EP300—ocular cancer	0.000734	0.000734	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—TGFB1—ocular cancer	0.000731	0.000731	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—GNAQ—ocular cancer	0.00073	0.00073	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—HDAC1—ocular cancer	0.000722	0.000722	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GNAQ—ocular cancer	0.00072	0.00072	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—HDAC1—ocular cancer	0.000716	0.000716	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CDKN2B—ocular cancer	0.00071	0.00071	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—HDAC1—ocular cancer	0.000706	0.000706	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—GNA11—ocular cancer	0.000697	0.000697	CbGpPWpGaD
Droxidopa—PAH—Metabolism—AKT1—ocular cancer	0.000685	0.000685	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—TGFB1—ocular cancer	0.000683	0.000683	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—HDAC1—ocular cancer	0.000668	0.000668	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—HDAC1—ocular cancer	0.000658	0.000658	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—E2F1—ocular cancer	0.000652	0.000652	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—GNAQ—ocular cancer	0.000648	0.000648	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—GNA11—ocular cancer	0.000648	0.000648	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CDKN2B—ocular cancer	0.000647	0.000647	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CDKN2B—ocular cancer	0.000641	0.000641	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—EP300—ocular cancer	0.000638	0.000638	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CDKN2B—ocular cancer	0.000633	0.000633	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MDM2—ocular cancer	0.000605	0.000605	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—GNAQ—ocular cancer	0.000602	0.000602	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—TP53—ocular cancer	0.000602	0.000602	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CDKN2B—ocular cancer	0.000599	0.000599	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—E2F1—ocular cancer	0.000594	0.000594	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CDKN2B—ocular cancer	0.00059	0.00059	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—E2F1—ocular cancer	0.000589	0.000589	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—HDAC1—ocular cancer	0.000584	0.000584	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—E2F1—ocular cancer	0.000581	0.000581	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—HRAS—ocular cancer	0.000576	0.000576	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—TP53—ocular cancer	0.000562	0.000562	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—HRAS—ocular cancer	0.000562	0.000562	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—TGFB1—ocular cancer	0.000555	0.000555	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CDKN1B—ocular cancer	0.000552	0.000552	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—E2F1—ocular cancer	0.00055	0.00055	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—AKT1—ocular cancer	0.000546	0.000546	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—HDAC1—ocular cancer	0.000543	0.000543	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—E2F1—ocular cancer	0.000541	0.000541	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—HRAS—ocular cancer	0.000538	0.000538	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CCND1—ocular cancer	0.000527	0.000527	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CDKN2B—ocular cancer	0.000524	0.000524	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CDKN1A—ocular cancer	0.00051	0.00051	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—AKT1—ocular cancer	0.000508	0.000508	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—AKT1—ocular cancer	0.000496	0.000496	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CDKN2B—ocular cancer	0.000487	0.000487	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—EP300—ocular cancer	0.000485	0.000485	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—E2F1—ocular cancer	0.000481	0.000481	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—AKT1—ocular cancer	0.000475	0.000475	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—TP53—ocular cancer	0.000457	0.000457	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—E2F1—ocular cancer	0.000447	0.000447	CbGpPWpGaD
Droxidopa—DDC—Metabolism—AKT1—ocular cancer	0.000443	0.000443	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—HRAS—ocular cancer	0.000437	0.000437	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MYC—ocular cancer	0.000423	0.000423	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TGFB1—ocular cancer	0.000422	0.000422	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MDM2—ocular cancer	0.000394	0.000394	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—AKT1—ocular cancer	0.000386	0.000386	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—HRAS—ocular cancer	0.000366	0.000366	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CDKN1B—ocular cancer	0.00036	0.00036	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MDM2—ocular cancer	0.000359	0.000359	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—AKT1—ocular cancer	0.000356	0.000356	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MDM2—ocular cancer	0.000356	0.000356	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MDM2—ocular cancer	0.000351	0.000351	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TP53—ocular cancer	0.000347	0.000347	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCND1—ocular cancer	0.000343	0.000343	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—HRAS—ocular cancer	0.000334	0.000334	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MDM2—ocular cancer	0.000332	0.000332	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CDKN1A—ocular cancer	0.000332	0.000332	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—HRAS—ocular cancer	0.000332	0.000332	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—HRAS—ocular cancer	0.00033	0.00033	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CDKN1B—ocular cancer	0.000328	0.000328	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MDM2—ocular cancer	0.000327	0.000327	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—HRAS—ocular cancer	0.000326	0.000326	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CDKN1B—ocular cancer	0.000325	0.000325	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—AKT1—ocular cancer	0.000324	0.000324	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—AKT1—ocular cancer	0.000323	0.000323	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—AKT1—ocular cancer	0.000321	0.000321	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CDKN1B—ocular cancer	0.000321	0.000321	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—EP300—ocular cancer	0.000319	0.000319	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—AKT1—ocular cancer	0.000317	0.000317	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—EP300—ocular cancer	0.000316	0.000316	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCND1—ocular cancer	0.000313	0.000313	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCND1—ocular cancer	0.00031	0.00031	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—HRAS—ocular cancer	0.000309	0.000309	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCND1—ocular cancer	0.000306	0.000306	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—HRAS—ocular cancer	0.000304	0.000304	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CDKN1B—ocular cancer	0.000303	0.000303	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CDKN1A—ocular cancer	0.000303	0.000303	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—AKT1—ocular cancer	0.0003	0.0003	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CDKN1A—ocular cancer	0.0003	0.0003	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CDKN1B—ocular cancer	0.000299	0.000299	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CDKN1A—ocular cancer	0.000296	0.000296	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—AKT1—ocular cancer	0.000295	0.000295	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—AKT1—ocular cancer	0.000295	0.000295	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—AKT1—ocular cancer	0.000293	0.000293	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—AKT1—ocular cancer	0.000292	0.000292	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MDM2—ocular cancer	0.000291	0.000291	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCND1—ocular cancer	0.000289	0.000289	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—AKT1—ocular cancer	0.000288	0.000288	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—EP300—ocular cancer	0.000288	0.000288	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—EP300—ocular cancer	0.000285	0.000285	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCND1—ocular cancer	0.000285	0.000285	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—EP300—ocular cancer	0.000282	0.000282	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CDKN1A—ocular cancer	0.00028	0.00028	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CDKN1A—ocular cancer	0.000276	0.000276	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MYC—ocular cancer	0.000275	0.000275	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TGFB1—ocular cancer	0.000275	0.000275	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—AKT1—ocular cancer	0.000273	0.000273	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MDM2—ocular cancer	0.00027	0.00027	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—HRAS—ocular cancer	0.00027	0.00027	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—AKT1—ocular cancer	0.000268	0.000268	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—EP300—ocular cancer	0.000266	0.000266	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CDKN1B—ocular cancer	0.000265	0.000265	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—AKT1—ocular cancer	0.000262	0.000262	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—EP300—ocular cancer	0.000262	0.000262	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—EP300—ocular cancer	0.000259	0.000259	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCND1—ocular cancer	0.000253	0.000253	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MYC—ocular cancer	0.000251	0.000251	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—HRAS—ocular cancer	0.000251	0.000251	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TGFB1—ocular cancer	0.00025	0.00025	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MYC—ocular cancer	0.000249	0.000249	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TGFB1—ocular cancer	0.000248	0.000248	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CDKN1B—ocular cancer	0.000246	0.000246	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MYC—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CDKN1A—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TGFB1—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—AKT1—ocular cancer	0.000244	0.000244	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—AKT1—ocular cancer	0.000238	0.000238	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCND1—ocular cancer	0.000235	0.000235	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—EP300—ocular cancer	0.000233	0.000233	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MYC—ocular cancer	0.000232	0.000232	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TGFB1—ocular cancer	0.000232	0.000232	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MYC—ocular cancer	0.000229	0.000229	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TGFB1—ocular cancer	0.000228	0.000228	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CDKN1A—ocular cancer	0.000227	0.000227	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TP53—ocular cancer	0.000226	0.000226	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—AKT1—ocular cancer	0.000221	0.000221	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—EP300—ocular cancer	0.000216	0.000216	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—HRAS—ocular cancer	0.000216	0.000216	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TP53—ocular cancer	0.000206	0.000206	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TP53—ocular cancer	0.000204	0.000204	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MYC—ocular cancer	0.000203	0.000203	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TGFB1—ocular cancer	0.000202	0.000202	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TP53—ocular cancer	0.000202	0.000202	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—HRAS—ocular cancer	0.000197	0.000197	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—HRAS—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—HRAS—ocular cancer	0.000193	0.000193	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—AKT1—ocular cancer	0.000193	0.000193	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—AKT1—ocular cancer	0.000191	0.000191	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TP53—ocular cancer	0.000191	0.000191	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MYC—ocular cancer	0.000189	0.000189	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TGFB1—ocular cancer	0.000188	0.000188	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TP53—ocular cancer	0.000188	0.000188	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—HRAS—ocular cancer	0.000182	0.000182	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—HRAS—ocular cancer	0.000179	0.000179	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—AKT1—ocular cancer	0.000174	0.000174	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—AKT1—ocular cancer	0.000172	0.000172	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—AKT1—ocular cancer	0.00017	0.00017	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TP53—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—AKT1—ocular cancer	0.000161	0.000161	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—HRAS—ocular cancer	0.000159	0.000159	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—AKT1—ocular cancer	0.000158	0.000158	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—AKT1—ocular cancer	0.000156	0.000156	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TP53—ocular cancer	0.000155	0.000155	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—HRAS—ocular cancer	0.000148	0.000148	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—AKT1—ocular cancer	0.000141	0.000141	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AKT1—ocular cancer	0.000131	0.000131	CbGpPWpGaD
